Back
Politics

Senate Hearing Questions RFK Jr.'s 'Wellness Farms' Proposal for Addiction Treatment

View source

In a Senate hearing, Health Secretary Robert F. Kennedy Jr. defended his proposal for 'wellness farms' as an alternative to medication-assisted addiction treatment, drawing sharp scrutiny over the model's rejection of standard medical protocols.

WASHINGTON, D.C.

During a recent Senate hearing, Senator Angela Alsobrooks questioned Health Secretary Robert F. Kennedy Jr. regarding his proposal to establish "wellness farms" as a new model for addiction treatment in the United States. Kennedy has previously cited Italy's San Patrignano community as the inspiration for these facilities.

Kennedy had specifically suggested the model could help "Black children" recover from addiction, framing the farms as a holistic alternative to traditional drug treatment.

However, the proposal has drawn significant criticism, primarily centered on San Patrignano's firm rejection of medication-assisted treatment (MAT). MAT, which involves the use of medications such as methadone and buprenorphine, is considered the standard of care in the U.S. for opioid and alcohol addiction.

The San Patrignano Model

The Italian facility, which currently houses approximately 850 residents, operates on a strict philosophy of abstinence, work, and community. While proponents praise its structured environment, the facility explicitly prohibits the use of medications like methadone and buprenorphine.

Research consistently demonstrates that medication-assisted treatment significantly reduces the risk of relapse and fatal overdose.

Kennedy's Stance

Secretary Kennedy defended his position during the hearing, stating that medications should not be the primary solution for addiction. Instead, he advocates for faith-based, abstinence-focused programs as a more effective long-term approach.

Critics argue that rejecting MAT ignores the biological nature of addiction and could endanger lives, particularly for those with severe opioid use disorders. The debate highlights a fundamental divide between holistic, community-based recovery models and the evidence-based pharmacological interventions currently recommended by U.S. health authorities.